Please login to the form below
Healthcare terms - G
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare terms - G
- Global Health Observatory
- Gatekeeper
- General practitioner (GP)
- Generic medicine
- Generic name
- Genome
- Geo-demographics
- Glass ceiling
- Global brand
- Global Health Index
- Global marketing
- Grey market
- Grey marketing (also called parallel importing)
- Greying, leisured, affluent, middle-aged (GLAM)
- Gross Domestic Product (GDP)
- Group dynamics
- Growth stage
- Guarantees and warranties
- Guerrilla marketing
- Guppie
- Gutter
Featured jobs
-
Account Director, Medical Education
-
Salary TBC
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
-
Senior Medical Writer
-
Salary TBC
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Competitive salary plus benefits
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
-
Senior Copywriter
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
-
Events Executive
-
DOE
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
Subscribe to our email news alerts
- Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
- GSK forms cell therapy R&D pact with star-studded biotech
- UCB gets bigger in rare diseases with $2.1bn purchase of Ra Pharma
- Gilead builds case for Descovy PrEP after FDA approval
- Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
- J&J hit by $8bn judgment for man claiming breast growth due to Risperdal
- The era of digital wellbeing
- Increased discount leads NICE to reverse positon on Clovis cancer drug
- Looking after the mental health of the Porterhouse family
- Bayer opens AI-enabled drug discovery center in UK
- In a U-turn, ICER takes more positive view of AbbVie’s Rinvoq
- Roche’s MabThera beats incumbent drug in pemphigus vulgaris phase 3
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Quick links
Infographics
